Birdwatch Archive

Birdwatch Note

2024-04-06 00:40:59 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING

これは下記の副反応疑い報告DBです https://covid-vaccine.jp/pfizer-medi?limit=50&sort1=no&symptom=%E5%B0%BF%E7%B4%B0%E7%AE%A1%E9%96%93%E8%B3%AA%E6%80%A7%E8%85%8E%E7%82%8E https://covid-vaccine.jp/moderna-medi?limit=50&sort1=no&symptom=%E5%B0%BF%E7%B4%B0%E7%AE%A1%E9%96%93%E8%B3%AA%E6%80%A7%E8%85%8E%E7%82%8E この副反応疑い報告は厚生労働省によると 因果関係があるかわからない、または直ちに判断できない例も報告対象で↓ https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/vaccine_hukuhannou-utagai-houkoku.html この報告にある病が副反応として認められたという意味ではなく厚労省のこれまで認められた副反応の中にも心筋炎等と違い尿細管間質性腎炎は入っていません↓ https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/vaccine_qa.html#23 またワクチンはDBの扱う22年春頃までで2.7億回国内で接種し↓ https://web.archive.org/web/20220616162341/https://info.vrs.digital.go.jp/dashboard/ この疑い報告ですらDBに尿細管間質性腎炎は入力部分までで3例(うち報告者が因果関係を判断したものは1例)しか存在せず疑い報告ですら報告がほぼ存在してない事に注意が必要です

Written by F4D2E4CA66E08B99BDDE8328BBF4C2313B853B3595C8AC38600E463328C72D9D
Participant Details

Original Tweet

Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1776372995482955889

Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.

All Information

  • ID - 1776409736315080917
  • noteId - 1776409736315080917
  • participantId -
  • noteAuthorParticipantId - F4D2E4CA66E08B99BDDE8328BBF4C2313B853B3595C8AC38600E463328C72D9D Participant Details
  • createdAtMillis - 1712364059894
  • tweetId - 1776372995482955889
  • classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
  • believable -
  • harmful -
  • validationDifficulty -
  • misleadingOther - 0
  • misleadingFactualError - 1
  • misleadingManipulatedMedia - 1
  • misleadingOutdatedInformation - 0
  • misleadingMissingImportantContext - 1
  • misleadingUnverifiedClaimAsFact - 1
  • misleadingSatire - 0
  • notMisleadingOther - 0
  • notMisleadingFactuallyCorrect - 0
  • notMisleadingOutdatedButNotWhenWritten - 0
  • notMisleadingClearlySatire - 0
  • notMisleadingPersonalOpinion - 0
  • trustworthySources - 1
  • summary
    • これは下記の副反応疑い報告DBです https://covid-vaccine.jp/pfizer-medi?limit=50&sort1=no&symptom=%E5%B0%BF%E7%B4%B0%E7%AE%A1%E9%96%93%E8%B3%AA%E6%80%A7%E8%85%8E%E7%82%8E https://covid-vaccine.jp/moderna-medi?limit=50&sort1=no&symptom=%E5%B0%BF%E7%B4%B0%E7%AE%A1%E9%96%93%E8%B3%AA%E6%80%A7%E8%85%8E%E7%82%8E この副反応疑い報告は厚生労働省によると 因果関係があるかわからない、または直ちに判断できない例も報告対象で↓ https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/vaccine_hukuhannou-utagai-houkoku.html この報告にある病が副反応として認められたという意味ではなく厚労省のこれまで認められた副反応の中にも心筋炎等と違い尿細管間質性腎炎は入っていません↓ https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/vaccine_qa.html#23 またワクチンはDBの扱う22年春頃までで2.7億回国内で接種し↓ https://web.archive.org/web/20220616162341/https://info.vrs.digital.go.jp/dashboard/ この疑い報告ですらDBに尿細管間質性腎炎は入力部分までで3例(うち報告者が因果関係を判断したものは1例)しか存在せず疑い報告ですら報告がほぼ存在してない事に注意が必要です

Note Status History

createdAt timestampMillisOfFirstNonNMRStatus firstNonNMRStatus timestampMillisOfCurrentStatus currentStatus timestampMillisOfLatestNonNMRStatus mostRecentNonNMRStatus participantId
2024-04-06 00:40:59 UTC
(1712364059894)
2024-04-06 16:34:27 UTC
(1712421267499)
CURRENTLY_RATED_HELPFUL 2024-04-07 02:42:43 UTC
(1712457763632)
NEEDS_MORE_RATINGS 2024-04-06 16:34:27 UTC
(1712421267499)
CURRENTLY_RATED_HELPFUL

Note Ratings

rated at rated by
2024-04-06 08:51:53 -0500 Rating Details
2024-04-06 06:35:44 -0500 Rating Details
2024-04-06 06:29:01 -0500 Rating Details
2024-04-06 06:09:06 -0500 Rating Details
2024-04-06 04:21:34 -0500 Rating Details
2024-04-06 04:09:55 -0500 Rating Details
2024-04-06 04:09:04 -0500 Rating Details
2024-04-06 03:13:02 -0500 Rating Details
2024-04-06 03:07:21 -0500 Rating Details
2024-04-06 02:55:17 -0500 Rating Details
2024-04-06 02:20:43 -0500 Rating Details
2024-04-06 01:35:43 -0500 Rating Details
2024-04-06 01:02:03 -0500 Rating Details
2024-04-05 23:50:01 -0500 Rating Details
2024-04-05 23:23:07 -0500 Rating Details
2024-04-05 23:19:58 -0500 Rating Details
2024-04-05 22:04:57 -0500 Rating Details
2024-04-05 21:18:12 -0500 Rating Details
2024-04-05 21:15:38 -0500 Rating Details
2024-04-05 21:12:37 -0500 Rating Details
2024-04-05 21:10:53 -0500 Rating Details
2024-04-05 20:57:47 -0500 Rating Details
2024-04-05 20:57:32 -0500 Rating Details
2024-04-05 20:32:52 -0500 Rating Details
2024-04-05 20:27:58 -0500 Rating Details
2024-04-05 20:17:56 -0500 Rating Details
2024-04-05 20:11:31 -0500 Rating Details
2024-04-12 17:29:32 -0500 Rating Details
2024-04-12 08:14:34 -0500 Rating Details
2024-04-13 02:25:04 -0500 Rating Details
2024-04-12 17:04:27 -0500 Rating Details
2024-04-09 10:44:29 -0500 Rating Details
2024-04-07 23:54:06 -0500 Rating Details
2024-04-06 11:33:11 -0500 Rating Details
2024-04-06 09:49:00 -0500 Rating Details
2024-04-06 04:31:49 -0500 Rating Details
2024-04-06 04:00:55 -0500 Rating Details
2024-04-06 03:49:23 -0500 Rating Details
2024-04-06 03:41:27 -0500 Rating Details
2024-04-06 03:11:00 -0500 Rating Details
2024-04-06 02:44:53 -0500 Rating Details
2024-04-06 01:39:07 -0500 Rating Details
2024-04-06 01:28:03 -0500 Rating Details
2024-04-06 01:15:53 -0500 Rating Details
2024-04-05 23:20:14 -0500 Rating Details
2024-04-05 22:06:30 -0500 Rating Details
2024-04-05 22:05:13 -0500 Rating Details
2024-04-05 21:55:18 -0500 Rating Details
2024-04-05 21:34:26 -0500 Rating Details
2024-04-05 21:32:58 -0500 Rating Details
2024-04-05 21:31:46 -0500 Rating Details
2024-04-05 20:58:06 -0500 Rating Details
2024-04-05 20:47:16 -0500 Rating Details
2024-04-05 20:37:17 -0500 Rating Details
2024-04-05 20:36:13 -0500 Rating Details
2024-04-05 20:26:08 -0500 Rating Details
2024-04-05 19:50:31 -0500 Rating Details
2024-04-12 18:14:19 -0500 Rating Details
2024-04-12 17:08:16 -0500 Rating Details
2024-04-12 17:01:53 -0500 Rating Details
2024-04-12 08:48:43 -0500 Rating Details
2024-04-12 08:23:45 -0500 Rating Details
2024-05-26 09:45:10 -0500 Rating Details
2024-06-21 05:20:31 -0500 Rating Details